1st Quarter - Report

AMBULATORY SURGERY CENTER ASSOCIATION for AMBULATORY SURGERY CENTER ASSOCIATION

Firm
Client
Income
—
Expenses
$180,599
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.1838/S.1001 - Ambulatory Surgical Center Quality and Access Act of 2017 H.R.1017/S.479 - Removing Barriers to Colorectal Cancer Screening Act of 2017 H.R.4679 - Ensuring Equal Access to Treatments Act of 2017 H.R.1628 - American Health Care Act of 2017 Reform of Medicare payments to ASCs Reform of Medicare regulations dealing with ASCs

LobbyistCovered position, as disclosed
JEFF EVANS New —
HEATHER FALEN ASHBY —
STEVE MILLER —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 479 (115th), S. 1001 (115th), H.R. 1017 (115th), H.R. 1838 (115th), H.R. 4679 (115th), H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.